Login to Your Account

Other News To Note

Thursday, July 28, 2011
Trius Therapeutics Inc., of San Diego, will collaborate with Bayer Pharma AG, of Leverkusen, Germany, to develop and commercialize Trius' lead Phase III antibiotic, torezolid phosphate, in Africa, Asia (excluding North and South Korea), Latin America and the Middle East.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription